The U.S. Food and Drug Administration (FDA) intends to negotiate a Firm Fixed Price sole source purchase order with TessArae,LLC.  Located at 858 Horton Street, Suite 555 Emeryville, CA 94608 for the acquisition of microarrays sequenced as follows (Array, FDAGUTA520821F) and (Array, FDAECSGa520423F).

The microarrays are unique products that are licensed exclusively by TessArae, LLC. Therefore, is the only responsible source to provide the necessary Service and replacement of parts to support FDA’s mission.

In accordance with FAR 5.207(c)(16)(ii), vendors that feel they can meet the Government's requirements detailed above may submit a capability statement which shall be considered by the agency. A determination by the Government not to open the requirement to competition based on responses to this notice is solely within the discretion of the Government. In accordance with FAR 6.305(a) the justification will be made publicly available within 14 days after award has been made. The acquisition will be conducted through the Federal Acquisition Regulation (FAR) Part 13 "Simplified Acquisition Procedures". The North American Industry Classification System (NAICS) code for this requirement is.811219 The business size standard is $19 million.